In this study, we have investigated copeptin, the biochemically stable C-terminal fragment of prepro-arginine vasopressin (AVP), as a novel biomarker to predict long-term neurodevelopmental outcome after birth asphyxia, with parallel comparative assays of NSE. This evidence concerns the gene AVP and asphyxia.